European Society for Radiotherapy and Oncology (ESTRO)
@estroradiotherapy.bsky.social
📸 Today’s Board meeting at the ESTRO office! Fruitful strategic discussions, productive exchanges, and a positive, collaborative spirit throughout.
🙏 Thank you everyone for joining and contributing — great to see the team working together to drive ESTRO forward. ✨
🙏 Thank you everyone for joining and contributing — great to see the team working together to drive ESTRO forward. ✨
November 27, 2025 at 4:47 PM
📸 Today’s Board meeting at the ESTRO office! Fruitful strategic discussions, productive exchanges, and a positive, collaborative spirit throughout.
🙏 Thank you everyone for joining and contributing — great to see the team working together to drive ESTRO forward. ✨
🙏 Thank you everyone for joining and contributing — great to see the team working together to drive ESTRO forward. ✨
📢Join the ESTRO Particle Therapy course and dive into proton & carbon ion therapy with global experts.
⏳ Early deadline: 17 Dec 2025
Led by Tony Lomax & Beate Timmermann, this course covers treatment planning, RBE, beam delivery, QA & more🔗 bit.ly/483Qbue
#Radonc
⏳ Early deadline: 17 Dec 2025
Led by Tony Lomax & Beate Timmermann, this course covers treatment planning, RBE, beam delivery, QA & more🔗 bit.ly/483Qbue
#Radonc
November 27, 2025 at 3:41 PM
📢Join the ESTRO Particle Therapy course and dive into proton & carbon ion therapy with global experts.
⏳ Early deadline: 17 Dec 2025
Led by Tony Lomax & Beate Timmermann, this course covers treatment planning, RBE, beam delivery, QA & more🔗 bit.ly/483Qbue
#Radonc
⏳ Early deadline: 17 Dec 2025
Led by Tony Lomax & Beate Timmermann, this course covers treatment planning, RBE, beam delivery, QA & more🔗 bit.ly/483Qbue
#Radonc
✨ Great energy at the #RTT Committee meeting in Brussels! Driving RTT #education, #research, #advocacy, #guidelines, global collaboration, and preparing for #ESTRO26.
🙏 A big thank you to all committee members for their ideas and commitment!
🙏 A big thank you to all committee members for their ideas and commitment!
November 26, 2025 at 9:55 AM
✨ Great energy at the #RTT Committee meeting in Brussels! Driving RTT #education, #research, #advocacy, #guidelines, global collaboration, and preparing for #ESTRO26.
🙏 A big thank you to all committee members for their ideas and commitment!
🙏 A big thank you to all committee members for their ideas and commitment!
Intensity-modulated moderately hypofractionated radiotherapy versus SBRT for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial, published in The Lancet Oncology.
👉 Read it before your patients: bit.ly/4oHNe8m
👉 Read it before your patients: bit.ly/4oHNe8m
November 26, 2025 at 8:47 AM
Intensity-modulated moderately hypofractionated radiotherapy versus SBRT for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial, published in The Lancet Oncology.
👉 Read it before your patients: bit.ly/4oHNe8m
👉 Read it before your patients: bit.ly/4oHNe8m
How is adaptive #radiotherapy redefining precision care? The ESTRO #IGRT 2025 course showcased:
✅ RTT-led workflows
✅ AI-assisted planning
✅ MR & CT guidance
✅ Practical, interactive learning
👉 Read the full report: bit.ly/4rnMLKj
#AdaptiveRT #ESTROSchool
✅ RTT-led workflows
✅ AI-assisted planning
✅ MR & CT guidance
✅ Practical, interactive learning
👉 Read the full report: bit.ly/4rnMLKj
#AdaptiveRT #ESTROSchool
November 26, 2025 at 8:46 AM
How is adaptive #radiotherapy redefining precision care? The ESTRO #IGRT 2025 course showcased:
✅ RTT-led workflows
✅ AI-assisted planning
✅ MR & CT guidance
✅ Practical, interactive learning
👉 Read the full report: bit.ly/4rnMLKj
#AdaptiveRT #ESTROSchool
✅ RTT-led workflows
✅ AI-assisted planning
✅ MR & CT guidance
✅ Practical, interactive learning
👉 Read the full report: bit.ly/4rnMLKj
#AdaptiveRT #ESTROSchool
🔔 Join us on 1 Dec at 15:00 CET for the 3rd ESTRO session on Functional Imaging in Reirradiation.
Experts will cover radiomics, dose painting, PET tracers & more.
Don’t miss it!
Register 👉 bit.ly/4os4U7m
Programme 👉 bit.ly/3JuqEkg
#Reirradiation #ESTROwebinar
Experts will cover radiomics, dose painting, PET tracers & more.
Don’t miss it!
Register 👉 bit.ly/4os4U7m
Programme 👉 bit.ly/3JuqEkg
#Reirradiation #ESTROwebinar
November 25, 2025 at 12:04 PM
🔔 Join us on 1 Dec at 15:00 CET for the 3rd ESTRO session on Functional Imaging in Reirradiation.
Experts will cover radiomics, dose painting, PET tracers & more.
Don’t miss it!
Register 👉 bit.ly/4os4U7m
Programme 👉 bit.ly/3JuqEkg
#Reirradiation #ESTROwebinar
Experts will cover radiomics, dose painting, PET tracers & more.
Don’t miss it!
Register 👉 bit.ly/4os4U7m
Programme 👉 bit.ly/3JuqEkg
#Reirradiation #ESTROwebinar
🌟 Join the ESTRO ROSQC! Help advance #safety & quality in #radiotherapy with a dynamic, multidisciplinary team. Open to all #radonc professionals.
📅 Apply by 1 Dec 2025
➡️ bit.ly/4pm6wB3
📅 Apply by 1 Dec 2025
➡️ bit.ly/4pm6wB3
November 25, 2025 at 8:46 AM
🌟 Join the ESTRO ROSQC! Help advance #safety & quality in #radiotherapy with a dynamic, multidisciplinary team. Open to all #radonc professionals.
📅 Apply by 1 Dec 2025
➡️ bit.ly/4pm6wB3
📅 Apply by 1 Dec 2025
➡️ bit.ly/4pm6wB3
Elderly #HeadAndNeckCancer patients are underrepresented in trials, making treatment decisions tough.
✅Share your clinical experience (oro-/hypopharynx, larynx, oral cavity) to guide future care.
🕐~10 min
📅Deadline: 19 Dec
👉Join the survey: bit.ly/46snipr
#radonc #radiotherapy
✅Share your clinical experience (oro-/hypopharynx, larynx, oral cavity) to guide future care.
🕐~10 min
📅Deadline: 19 Dec
👉Join the survey: bit.ly/46snipr
#radonc #radiotherapy
November 25, 2025 at 8:28 AM
Elderly #HeadAndNeckCancer patients are underrepresented in trials, making treatment decisions tough.
✅Share your clinical experience (oro-/hypopharynx, larynx, oral cavity) to guide future care.
🕐~10 min
📅Deadline: 19 Dec
👉Join the survey: bit.ly/46snipr
#radonc #radiotherapy
✅Share your clinical experience (oro-/hypopharynx, larynx, oral cavity) to guide future care.
🕐~10 min
📅Deadline: 19 Dec
👉Join the survey: bit.ly/46snipr
#radonc #radiotherapy
Can #AI revolutionise #brachytherapy planning for #cervicalcancer? A new prospective study from Erasmus MC shows that use of the BiCycle autoplanning system for cervical cancer can cut planning time by 80% while producing top-quality plans.
👉 bit.ly/3JGvHyp #radonc
👉 bit.ly/3JGvHyp #radonc
November 24, 2025 at 8:50 AM
Can #AI revolutionise #brachytherapy planning for #cervicalcancer? A new prospective study from Erasmus MC shows that use of the BiCycle autoplanning system for cervical cancer can cut planning time by 80% while producing top-quality plans.
👉 bit.ly/3JGvHyp #radonc
👉 bit.ly/3JGvHyp #radonc
Focused minds, expert speakers, and meaningful discussions — this is how we advance brachytherapy at the GEC-ESTRO Workshop. 💡🎤
#ESTROGEC25 #Brachytherapy
#ESTROGEC25 #Brachytherapy
November 20, 2025 at 2:32 PM
Focused minds, expert speakers, and meaningful discussions — this is how we advance brachytherapy at the GEC-ESTRO Workshop. 💡🎤
#ESTROGEC25 #Brachytherapy
#ESTROGEC25 #Brachytherapy
Meet new ROSQC member Carl Rowbottom!
Carl Rowbottom, director of physics at the Clatterbridge Cancer Centre, brings expertise in medical physics, patient safety, and AI in radiotherapy.
👉 bit.ly/49oYceu
#Radiotherapy #PatientSafety #MedicalPhysics
Carl Rowbottom, director of physics at the Clatterbridge Cancer Centre, brings expertise in medical physics, patient safety, and AI in radiotherapy.
👉 bit.ly/49oYceu
#Radiotherapy #PatientSafety #MedicalPhysics
November 20, 2025 at 8:17 AM
Meet new ROSQC member Carl Rowbottom!
Carl Rowbottom, director of physics at the Clatterbridge Cancer Centre, brings expertise in medical physics, patient safety, and AI in radiotherapy.
👉 bit.ly/49oYceu
#Radiotherapy #PatientSafety #MedicalPhysics
Carl Rowbottom, director of physics at the Clatterbridge Cancer Centre, brings expertise in medical physics, patient safety, and AI in radiotherapy.
👉 bit.ly/49oYceu
#Radiotherapy #PatientSafety #MedicalPhysics
#ARTTICON2025 endorsed by ESTRO
Insights from the Indian #RTT Community: expert lectures, inspiring panels on women in #radiotherapy, advanced RTT skills, and innovations in patient-centred care.
👉 bit.ly/47L3Aav
Insights from the Indian #RTT Community: expert lectures, inspiring panels on women in #radiotherapy, advanced RTT skills, and innovations in patient-centred care.
👉 bit.ly/47L3Aav
November 19, 2025 at 9:11 AM
#ARTTICON2025 endorsed by ESTRO
Insights from the Indian #RTT Community: expert lectures, inspiring panels on women in #radiotherapy, advanced RTT skills, and innovations in patient-centred care.
👉 bit.ly/47L3Aav
Insights from the Indian #RTT Community: expert lectures, inspiring panels on women in #radiotherapy, advanced RTT skills, and innovations in patient-centred care.
👉 bit.ly/47L3Aav
🌍 #ESTRO26: The Global Hub for #Radiation #Oncology #Innovation
Almost 4️⃣0️⃣% of abstracts are from outside Europe, covering all 5 continents!
✅ Join the global community in #radonc #research and connect with the brightest minds worldwide.
👉 bit.ly/4oT91tt
Almost 4️⃣0️⃣% of abstracts are from outside Europe, covering all 5 continents!
✅ Join the global community in #radonc #research and connect with the brightest minds worldwide.
👉 bit.ly/4oT91tt
November 18, 2025 at 4:00 PM
🌍 #ESTRO26: The Global Hub for #Radiation #Oncology #Innovation
Almost 4️⃣0️⃣% of abstracts are from outside Europe, covering all 5 continents!
✅ Join the global community in #radonc #research and connect with the brightest minds worldwide.
👉 bit.ly/4oT91tt
Almost 4️⃣0️⃣% of abstracts are from outside Europe, covering all 5 continents!
✅ Join the global community in #radonc #research and connect with the brightest minds worldwide.
👉 bit.ly/4oT91tt
Active monitoring, surgery, and radiotherapy for cribriform-positive and cribriform-negative prostate cancer: a secondary analysis of the PROTECT randomized clinical trial published in JAMA Oncology.
👉 Read it before your patients: bit.ly/3WWTGML
👉 Read it before your patients: bit.ly/3WWTGML
November 18, 2025 at 8:30 AM
Active monitoring, surgery, and radiotherapy for cribriform-positive and cribriform-negative prostate cancer: a secondary analysis of the PROTECT randomized clinical trial published in JAMA Oncology.
👉 Read it before your patients: bit.ly/3WWTGML
👉 Read it before your patients: bit.ly/3WWTGML
Long-term results of NRG/RTOG 9601, a randomized trial of radiation with or without antiandrogens in patients receiving salvage prostate bed radiation therapy postprostatectomy, published in the hashtag#RedJournal.
👉 Read it before your patients: shorturl.at/fi0VZ
👉 Read it before your patients: shorturl.at/fi0VZ
November 17, 2025 at 2:23 PM
Long-term results of NRG/RTOG 9601, a randomized trial of radiation with or without antiandrogens in patients receiving salvage prostate bed radiation therapy postprostatectomy, published in the hashtag#RedJournal.
👉 Read it before your patients: shorturl.at/fi0VZ
👉 Read it before your patients: shorturl.at/fi0VZ
🎥 “Radiotherapy innovations evolve fast — but fair appraisal is key to bringing value to patients.”
Prof Yolande Lievens explains how the #VBRO project is building the methods and partnerships to make that happen.
👉 Watch: bit.ly/4a3amcW
#ValueBasedCare #Oncology #ESTRO
Prof Yolande Lievens explains how the #VBRO project is building the methods and partnerships to make that happen.
👉 Watch: bit.ly/4a3amcW
#ValueBasedCare #Oncology #ESTRO
November 17, 2025 at 2:18 PM
🎥 “Radiotherapy innovations evolve fast — but fair appraisal is key to bringing value to patients.”
Prof Yolande Lievens explains how the #VBRO project is building the methods and partnerships to make that happen.
👉 Watch: bit.ly/4a3amcW
#ValueBasedCare #Oncology #ESTRO
Prof Yolande Lievens explains how the #VBRO project is building the methods and partnerships to make that happen.
👉 Watch: bit.ly/4a3amcW
#ValueBasedCare #Oncology #ESTRO
🌟 #ESTRO26 hits a new record! 🌟
4,091 abstracts submitted — over 500 more than last year! 🚀
Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
4,091 abstracts submitted — over 500 more than last year! 🚀
Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
November 13, 2025 at 4:04 PM
🌟 #ESTRO26 hits a new record! 🌟
4,091 abstracts submitted — over 500 more than last year! 🚀
Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
4,091 abstracts submitted — over 500 more than last year! 🚀
Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
Radiomics quality score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine, published in Nat Rev Clin Oncol.
👉 Read it before your patients: bit.ly/3JIaDr2
👉 Read it before your patients: bit.ly/3JIaDr2
November 12, 2025 at 7:25 AM
Radiomics quality score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine, published in Nat Rev Clin Oncol.
👉 Read it before your patients: bit.ly/3JIaDr2
👉 Read it before your patients: bit.ly/3JIaDr2
💡 How to fairly assess #radiotherapy #innovations? The new #VBRO paper proposes a framework categorising them as:
🔹Drug-centred
🔹Radiation-centred
🔹Radiation-enabling
🔹Operational
👉 Published in the Green Journal: bit.ly/4qIoaj5
🔹Drug-centred
🔹Radiation-centred
🔹Radiation-enabling
🔹Operational
👉 Published in the Green Journal: bit.ly/4qIoaj5
November 10, 2025 at 3:17 PM
💡 How to fairly assess #radiotherapy #innovations? The new #VBRO paper proposes a framework categorising them as:
🔹Drug-centred
🔹Radiation-centred
🔹Radiation-enabling
🔹Operational
👉 Published in the Green Journal: bit.ly/4qIoaj5
🔹Drug-centred
🔹Radiation-centred
🔹Radiation-enabling
🔹Operational
👉 Published in the Green Journal: bit.ly/4qIoaj5
🟢 ESTRO recommendations on preoperative radiation therapy in #breastcancer, just published in the Green Journal.
Endorsed by @astro-org.bsky.social.
👉 bit.ly/4qIdgtE
#radiotherapy #recommendations #GreenJournal #radonc
Endorsed by @astro-org.bsky.social.
👉 bit.ly/4qIdgtE
#radiotherapy #recommendations #GreenJournal #radonc
November 10, 2025 at 10:01 AM
🟢 ESTRO recommendations on preoperative radiation therapy in #breastcancer, just published in the Green Journal.
Endorsed by @astro-org.bsky.social.
👉 bit.ly/4qIdgtE
#radiotherapy #recommendations #GreenJournal #radonc
Endorsed by @astro-org.bsky.social.
👉 bit.ly/4qIdgtE
#radiotherapy #recommendations #GreenJournal #radonc
Boost your chest cancer imaging skills! Join the course on 24–25 Nov, for expert-led cases, interactive sessions & latest trends.
💻 Register: buff.ly/7EuB1bB
#Radiology #Oncology #ChestImaging #LungCancer
💻 Register: buff.ly/7EuB1bB
#Radiology #Oncology #ChestImaging #LungCancer
November 7, 2025 at 9:20 AM
Boost your chest cancer imaging skills! Join the course on 24–25 Nov, for expert-led cases, interactive sessions & latest trends.
💻 Register: buff.ly/7EuB1bB
#Radiology #Oncology #ChestImaging #LungCancer
💻 Register: buff.ly/7EuB1bB
#Radiology #Oncology #ChestImaging #LungCancer
📢Upcoming ESTRO webinar supported by IBA: 12 Nov, 16:00–17:30 CET Prof. Steven J. Frank presents the first Phase III IMPT vs IMRT trial for oropharyngeal cancer, moderated by Jon Cacicedo Fernandez de Bobadilla.
ℹ️ More info: bit.ly/47QQJmU
🔗 Register now (free & open to all): bit.ly/4hKkBoE
#ESTRO
ℹ️ More info: bit.ly/47QQJmU
🔗 Register now (free & open to all): bit.ly/4hKkBoE
#ESTRO
November 7, 2025 at 7:32 AM
📢Upcoming ESTRO webinar supported by IBA: 12 Nov, 16:00–17:30 CET Prof. Steven J. Frank presents the first Phase III IMPT vs IMRT trial for oropharyngeal cancer, moderated by Jon Cacicedo Fernandez de Bobadilla.
ℹ️ More info: bit.ly/47QQJmU
🔗 Register now (free & open to all): bit.ly/4hKkBoE
#ESTRO
ℹ️ More info: bit.ly/47QQJmU
🔗 Register now (free & open to all): bit.ly/4hKkBoE
#ESTRO
📢 Join us in Zagreb, Croatia (or online) for the ESTRO School course:
🎯 IMRT and VMAT: Best Practices and New Trends
🗓️ 1–4 March 2026
📌 Early reg: 🏫 3 Dec 2025 | 💻 7 Jan 2026
Explore the latest in treatment planning with top experts. 🔗https://bit.ly/4hVXLdF
#ESTROSchool26
🎯 IMRT and VMAT: Best Practices and New Trends
🗓️ 1–4 March 2026
📌 Early reg: 🏫 3 Dec 2025 | 💻 7 Jan 2026
Explore the latest in treatment planning with top experts. 🔗https://bit.ly/4hVXLdF
#ESTROSchool26
November 6, 2025 at 4:25 PM
📢 Join us in Zagreb, Croatia (or online) for the ESTRO School course:
🎯 IMRT and VMAT: Best Practices and New Trends
🗓️ 1–4 March 2026
📌 Early reg: 🏫 3 Dec 2025 | 💻 7 Jan 2026
Explore the latest in treatment planning with top experts. 🔗https://bit.ly/4hVXLdF
#ESTROSchool26
🎯 IMRT and VMAT: Best Practices and New Trends
🗓️ 1–4 March 2026
📌 Early reg: 🏫 3 Dec 2025 | 💻 7 Jan 2026
Explore the latest in treatment planning with top experts. 🔗https://bit.ly/4hVXLdF
#ESTROSchool26
⏳ It’s almost time for #ESTROGEC25!
Join us in Belgrade, 19–20 Nov, for “Brachytherapy – strength through open mind.”
Two days of innovation, collaboration & inspiration in image-guided brachytherapy.
👉 Register: bit.ly/3Tdcs0s
#ESTROGEC25
Join us in Belgrade, 19–20 Nov, for “Brachytherapy – strength through open mind.”
Two days of innovation, collaboration & inspiration in image-guided brachytherapy.
👉 Register: bit.ly/3Tdcs0s
#ESTROGEC25
November 6, 2025 at 7:59 AM
⏳ It’s almost time for #ESTROGEC25!
Join us in Belgrade, 19–20 Nov, for “Brachytherapy – strength through open mind.”
Two days of innovation, collaboration & inspiration in image-guided brachytherapy.
👉 Register: bit.ly/3Tdcs0s
#ESTROGEC25
Join us in Belgrade, 19–20 Nov, for “Brachytherapy – strength through open mind.”
Two days of innovation, collaboration & inspiration in image-guided brachytherapy.
👉 Register: bit.ly/3Tdcs0s
#ESTROGEC25
🚨 Call for Applications: TipsRO - Technical Innovations and Patient Support in Radiation Oncology, part of the ESTRO journal family, is seeking a new Associate Editor!
⏳ Apply by: 21 November
📆 Start: January 2026
ℹ bit.ly/4qYk1I6
⏳ Apply by: 21 November
📆 Start: January 2026
ℹ bit.ly/4qYk1I6
November 5, 2025 at 2:23 PM
🚨 Call for Applications: TipsRO - Technical Innovations and Patient Support in Radiation Oncology, part of the ESTRO journal family, is seeking a new Associate Editor!
⏳ Apply by: 21 November
📆 Start: January 2026
ℹ bit.ly/4qYk1I6
⏳ Apply by: 21 November
📆 Start: January 2026
ℹ bit.ly/4qYk1I6